Marsh & McLennan annual meeting results: all directors elected, say-on-pay approved, auditor ratified

MARSH & MCLENNAN COMPANIES, INC.

Annual meeting held May 21, 2026; 90.34% of outstanding shares represented (436.5M of 483.1M).
All 13 director nominees elected; largest 'against' votes were for Schapiro (31.3M), Mills (27.4M), Hanway (22.5M).
Say-on-pay passed with 362.1M for, 47.1M against, 2.1M abstain (86% of votes cast).
Ratification of Deloitte & Touche as auditor for 2026: 407.2M for, 28.0M against, 1.2M abstain.
Broker non-votes on director elections and say-on-pay: 25.2M shares; none on auditor ratification.

item 5.07

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000062709-26-000128
form_type: 8-K
ticker: MRSH
cik: 0000062709
company_name: MARSH & MCLENNAN COMPANIES, INC.
filed_at: 2026-05-22T20:02:06+00:00
discovered_at: 2026-05-22T20:03:00.306131+00:00
generated_at: 2026-05-22T20:06:51.703362+00:00
sec_items: ["5.07"]
event_type: other
sentiment: neutral
materiality_score: 0.25
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000062709-26-000128
json_url: https://secwatch.observer/filing/0000062709-26-000128.json
markdown_url: https://secwatch.observer/filing/0000062709-26-000128.md
text_url: https://secwatch.observer/filing/0000062709-26-000128.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/62709/000006270926000128/0000062709-26-000128-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/62709/000006270926000128/a2026mmcagmresultsform8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0000062709-26-000128

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.